PLX

PLX Total Non-Current Liabilities

$7.54MQuarterly · USD

Period ending:

PLX FY Total Non-Current LiabilitiesUSD
PLX FY Total Non-Current Liabilities1996-12-31: $7.26M1997-12-31: $7.38M1998-12-31: $47.94K1999-12-31: $0.002000-12-31: $0.002001-12-31: $0.002002-12-31: $0.002003-12-31: $0.002004-12-31: $0.002005-12-31: $0.002006-12-31: $436.00K2007-12-31: $690.00K2008-12-31: $937.00K2009-12-31: $61.26M2010-12-31: $57.15M2011-12-31: $59.19M2012-12-31: $56.33M2013-12-31: $113.58M2014-12-31: $107.86M2015-12-31: $75.15M2016-12-31: $25.99M2017-12-31: $80.76M2018-12-31: $88.66M2019-12-31: $75.54M2020-12-31: $8.50M2021-12-31: $46.53M2022-12-31: $34.00M2023-12-31: $5.34M2024-12-31: $4.59M2025-12-31: $7.60M$113.58M$0.00
1996-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

PLX total non-current liabilities history

Long-term obligations due beyond one year. The available annual fiscal periods series contains 30 observations from Dec 31, 1996 to Dec 31, 2025.

Protalix Biotherapeutics Inc Total Non-Current Liabilities — Annual fiscal periods (USD)
Period endingTotal Non-Current Liabilities (USD)
7,598,000
4,585,000
5,335,000
33,998,000
46,525,000
8,497,000
75,539,000
88,659,000
80,755,000
25,992,000
75,145,000
107,861,000
113,583,000
56,329,000
59,189,000
57,149,000
61,258,000
937,000
690,000
436,000
0
0
0
0
0
0
0
47,937
7,378,467
7,260,022

Compare total non-current liabilities

All PLX financial metrics · PLX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.